Literature DB >> 14147744

MELPHALAN IN THE TREATMENT OF MYELOMATOSIS.

D E SPEED, D A GALTON, A SWAN.   

Abstract

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; BLOOD PROTEINS; BLOOD SEDIMENTATION; CALCIUM; HEMOGLOBINOMETRY; LEUKOCYTE COUNT; MELPHALAN; MULTIPLE MYELOMA; NEOPLASM STATISTICS; PROGNOSIS; PROTEINURIA; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14147744      PMCID： PMC1814862          DOI： 10.1136/bmj.1.5399.1664

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  MELPHALAN THERAPY IN MYELOMATOSIS.

Authors:  J WALDENSTROEM
Journal:  Br Med J       Date:  1964-04-04

2.  CHEMOTHERAPY IN MYELOMATOSIS.

Authors:  J INNES; J NEWALL
Journal:  Proc R Soc Med       Date:  1963-08

3.  Multiple myelomatosis treated with a combination of urethane and an oral nitrogen mustard.

Authors:  J INNES; W D RIDER
Journal:  Blood       Date:  1955-03       Impact factor: 22.113

4.  Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.

Authors:  D E BERGSAGEL
Journal:  Cancer Chemother Rep       Date:  1962-02

5.  [Clinical experiences with sarcolysin in neoplastic diseases].

Authors:  N BLOKHIN; L LARIONOV; N PEREVODCHIKOVA; L CHEBOTAREVA; N MERKULOVA
Journal:  Ann N Y Acad Sci       Date:  1958-04-24       Impact factor: 5.691

6.  Cyclophosphamide in Hodgkin's disease and related disorders.

Authors:  J Q MATTHIAS; J J MISIEWICZ; R B SCOTT
Journal:  Br Med J       Date:  1960-12-24

7.  Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period.

Authors:  W F LUTTGENS; E D BAYRD
Journal:  J Am Med Assoc       Date:  1951-10-27
  7 in total
  12 in total

1.  CLINICAL TRIALS IN PROGRESS: LEUKAEMIA AND MULTIPLE MYELOMA.

Authors:  D A GALTON
Journal:  Proc R Soc Med       Date:  1965-08

Review 2.  Antineoplastic and immunosuppressive drugs. II. Therapeutic uses.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  [The therapy of the paraproteinemias].

Authors:  U Kanzow
Journal:  Blut       Date:  1969-05

4.  Management of multiple myeloma.

Authors:  J S Malpas
Journal:  Br Med J       Date:  1969-04-19

5.  The effect of 1-phenylalanine mustard on anti-globulin antibodies in multiple myeloma.

Authors:  M Waller; J H Moon; R Irby; E C Toone
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330

6.  Treatment of myelomatosis with fluoride.

Authors: 
Journal:  Br Med J       Date:  1967-04-15

7.  The function of androgens and fluoride salts in the treatment of multiple myeloma.

Authors:  F H Gardner; P Cohen
Journal:  Trans Am Clin Climatol Assoc       Date:  1966

8.  Pharmacokinetics of melphalan in children following high-dose intravenous injection.

Authors:  I A Taha; R A Ahmad; D W Rogers; J Pritchard; H J Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Myelomatosis: comparison of melphalan and cyclophosphamide therapy.

Authors: 
Journal:  Br Med J       Date:  1971-03-20

10.  Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma.

Authors:  I A Taha; R A Ahmad; H Gray; C I Roberts; H J Rogers
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.